01-03-2012: Agilent Technologies Inc. announced it has completed the acquisition of the BioSystem Development business. BioSystem Development is a privately held company that develops and manufactures the AssayMAP Microchromatography platform to meet the analytical needs of the life sciences industry. Financial details of the transaction were not disclosed.
As life science discovery and development continues to move toward a better understanding of biological responses to disease, and has an increased emphasis on protein-based therapeutics by pharmaceutical companies, the need for automated, quality protein sample preparation and analysis has become critical.
BioSystem Development’s AssayMAP platform, based on disposable microchromatography cartridges, enables for the first time, automation of complex, multi-step sample preparation workflows. These include protein purification, characterization and analysis solutions for bioprocess development, biomarker identification and analysis, as well as a variety of other life science research applications.
The acquisition formalizes and streamlines the ongoing collaboration between BioSystem Development and Agilent to combine AssayMAP technology with Agilent's industry-leading automated liquid handling platforms, to reduce discovery and development time and increase lab efficiency.
Contact / Request information
Request further information free of charge:
Agilent to Acquire Dako for $2.2 Billion
Agilent Technologies Inc. and EQT, the Sweden-based private equity group, announced the execution of a definitive agreement for Agilent to acquire Dako, the Denmark-based cancer diagnostic company. The $2.2 billion acquisition (on a debt-free basis) is the largest in Agilent’s history. “In ... more
Agilent Technologies and Universiti Putra Malaysia to Collaborate on Halal Food Research
Agilent Technologies Inc. and Universiti Putra Malaysia announced a collaboration to strengthen Malaysia’s research capabilities for halal food products, with particular emphasis on food authentication and food safety.“Halal” is an Arabic word meaning lawful or allowable. Any product deemed ... more
Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
Agilent Technologies Inc. announced that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration to develop new tools to detect and analyze pathogens in food. The joint R&D effort will also seek to improve DNA-based tools for confirmin ... more
Half a Century of Chromatography with Agilent and Predecessors
Twsett originated the chromatography with his work about the separation of chlorophyll in 1903. For some time it was relatively quite around this new technology. Exceptions were the workings of Kuhn and Lederer (1931) as well as of Hesse (1936 and 1942). A break through succeeded to E. Crem ... more
Agilent Technologies Completes Acquisition of BioSystem Development Business
Agilent Technologies Inc. announced it has completed the acquisition of the BioSystem Development business. BioSystem Development is a privately held company that develops and manufactures the AssayMAP Microchromatography platform to meet the analytical needs of the life sciences industry. ... more
BioSystem Development and BAC BV announced a collaboration to bring state-of-the-art high affinity ligands to the AssayMAP high-throughput micro-chromatography platform. This collaboration marks an essential objective toward growing a family of high-throughput tools for micro-scale purifica ... more
About analytica-world.com
analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
